- Home
- AWRE vs INMB Comparison
AWRE vs INMB Comparison
Compare AWRE & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AWRE
- INMB
- Stock Information
- Founded
- AWRE 1986
- INMB 2015
- Country
- AWRE United States
- INMB United States
- Employees
- AWRE N/A
- INMB N/A
- Industry
- AWRE Computer Software: Prepackaged Software
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- AWRE Technology
- INMB Health Care
- Exchange
- AWRE Nasdaq
- INMB Nasdaq
- Market Cap
- AWRE 56.1M
- INMB 55.0M
- IPO Year
- AWRE 1996
- INMB 2019
- Fundamental
- Price
- AWRE $2.45
- INMB $1.98
- Analyst Decision
- AWRE
- INMB Buy
- Analyst Count
- AWRE 0
- INMB 4
- Target Price
- AWRE N/A
- INMB $9.53
- AVG Volume (30 Days)
- AWRE 35.2K
- INMB 564.4K
- Earning Date
- AWRE 10-29-2025
- INMB 10-30-2025
- Dividend Yield
- AWRE N/A
- INMB N/A
- EPS Growth
- AWRE N/A
- INMB N/A
- EPS
- AWRE N/A
- INMB N/A
- Revenue
- AWRE $16,146,999.00
- INMB $50,000.00
- Revenue This Year
- AWRE N/A
- INMB $142.83
- Revenue Next Year
- AWRE N/A
- INMB $14,780.90
- P/E Ratio
- AWRE N/A
- INMB N/A
- Revenue Growth
- AWRE N/A
- INMB N/A
- 52 Week Low
- AWRE $1.35
- INMB $1.71
- 52 Week High
- AWRE $2.95
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- AWRE 47.11
- INMB 41.99
- Support Level
- AWRE $2.35
- INMB $1.92
- Resistance Level
- AWRE $2.84
- INMB $2.16
- Average True Range (ATR)
- AWRE 0.19
- INMB 0.11
- MACD
- AWRE -0.02
- INMB 0.03
- Stochastic Oscillator
- AWRE 26.55
- INMB 42.86
About AWRE Aware Inc.
Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.